News
Shares in Verve Therapeutics ( VERV -0.54%) soared 80.5% this week on the news of an agreement for Eli Lilly ( LLY -2.54%) to acquire Verve. The deal centers on an exciting cardiovascular health ...
Shares of Verve Therapeutics skyrocketed 75% Tuesday morning after Eli Lilly announced that it would acquire the gene-editing ...
Lilly confirmed it would buy a Boston-based clinical-stage company developing genetic medicines for cardiovascular disease.
Update: Adds deal confirmation Eli Lilly (NYSE:LLY) has agreed to acquire Boston-based gene editing startup Verve Therapeutics (NASDAQ:VERV) for up to $1.3B. Pursuant to the agreement, Lilly will ...
Eli Lilly will acquire gene-editing startup Verve Therapeutics for up to $1.3 billion, the companies said on Tuesday, ...
Verve Therapeutics VERV signed a definitive agreement with pharma bigwig Eli Lilly LLY. Per the terms, the pharma giant will acquire all outstanding shares of VERV for $10.50 per share in cash ...
South Korea's trade minister Yeo Han-koo will visit the United States from June 22 to 27, the trade ministry said on Saturday ...
The deal centers around a medicine that could “shift the treatment paradigm for cardiovascular disease,” Lilly said, but also follows a yearslong decline in Verve’s share price amid skepticism over ...
Eli Lilly and Company (NYSE: LLY) and Verve Therapeutics, Inc. (Nasdaq: VERV), a Boston-based clinical-stage company developing genetic medicines for cardiovascular disease, today announced a ...
Eli Lilly LLY-0.47 % decrease; red down pointing triangle agreed to acquire Verve Therapeutics VERV 0.45 % increase; green up pointing triangle for about $1 billion upfront, adding a potential ...
INDIANAPOLIS, June 17, 2025 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) and Verve Therapeutics, Inc. (Nasdaq: VERV), a Boston-based clinical-stage company developing genetic medicines for ...
--Eli Lilly and Company and Verve Therapeutics, Inc., a Boston- based clinical-stage company developing genetic medicines for cardiovascular disease, today announced a definitive agreement for ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results